Chelsea Clinton, Kleiner Perkins throw support behind Nurx, the 'Uber for birth control'
Telemedicine startup Nurx, which provides direct-to-consumer birth control and daily HIV prevention medication (PrEP) to patients whether or not they have health insurance, has raised $36 million in a Series B led by Kleiner Perkins Caufield & Byers. The round values the company at $100 million, per PitchBook data.
Dubbed the "Uber for birth control" in the media, Nurx offers a HIPAA-compliant platform that delivers contraceptives directly to customers' doorsteps and allows women to skip physical doctor's appointments, offering online access to a network of doctors and pharmacies that have partnered with the company. It's a business plan that's also drawn the support of Chelsea Clinton, who will join Nurx's board as part of the new funding.
News of the funding comes a day after US President Donald Trump announced conservative federal appeals court judge Brett Kavanaugh as his nominee to replace retiring Justice Anthony Kennedy on the Supreme Court, igniting a conversation around the future of women's healthcare. A majority-conservative court could reverse Roe v. Wade, the landmark 1973 case that made it illegal for states to ban abortion.
If the court does overturn Roe V. Wade, control over abortion regulations would return to each individual state. It's likely that 22 states would ban abortion without federal laws, according to a recent estimate from the Center for Reproductive Rights.
https://www.yahoo.com/news/chelsea-clinton-kpcb-throw-support-050000667.html